Version history

{
  "session_id": "sess_dfb32151-9c40-452d-8063-0c57bae5c3d6_task_66f1207e_recon",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "Skeptic critique for analysis dfb32151-9c40-452d-8063-0c57bae5c3d6: Sex-Specific Microglial States in Amyloid vs Tau Pathology and Cognitive Decline\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Sex-dependent molecular landscape of Alzheimer's disease revealed by large-scale single-cell transcriptomics could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: sex differences can be confounded by age, disease stage, hormone exposure, and cell-state annotation drift.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing sex-divergent microglial activation states and X-linked immune escape genes in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that amyloid-beta mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
  "tokens_used": "380",
  "persona_id": "persona-skeptic"
}